Nutriband Inc (NTRB)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$5.97+6.04%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NTRB
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 | Jan 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||
| Revenues | 1.6 | 2.0 | 2.1 | 2.1 | 2.1 | 1.4 | 0.9 | 0.1 | 0.2 | — | — |
| Total Revenues | 1.6 | 2.0 | 2.1 | 2.1 | 2.1 | 1.4 | 0.9 | 0.1 | 0.2 | — | — |
| Cost of Revenues | 1.1 | 1.5 | 1.4 | 1.9 | 1.8 | 1.2 | 0.6 | 0.5 | 0.3 | — | — |
| Gross Profit | — | 0.6 | 0.7 | — | 0.8 | 0.6 | 0.3 | — | — | — | — |
| Operating Expenses & Income | |||||||||||
| Selling, General & Admin | 6.4 | 7.0 | 4.3 | 3.8 | 3.9 | 4.0 | 2.9 | 1.8 | 3.3 | 0.2 | 0.2 |
| R&D Expenses | 1.2 | 1.9 | 3.1 | 2.0 | 1.0 | 0.4 | — | — | — | — | — |
| Other Operating Expenses, Total | — | — | — | — | — | (0.1) | 0.1 | — | — | — | — |
| Operating Income | (7.0) | (8.3) | (10.3) | (4.9) | (4.5) | (6.1) | (2.6) | (2.0) | (3.3) | (2.7) | (0.2) |
| Earnings from Continuing Operations | |||||||||||
| Interest Expense | — | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.3 | 0.1 | — | — | — |
| Interest & Investment Income | — | 0.1 | 0.2 | — | — | — | — | — | — | — | — |
| Other Non-Operating Income / Expenses | 0.1 | 0.1 | (0.2) | — | 5.2 | 6.6 | (0.3) | — | — | — | — |
| Asset Writedown | — | — | — | (1.1) | (1.1) | (1.0) | — | — | 2.5 | 2.5 | — |
| EBT, Incl. Unusual Items | (7.0) | (8.2) | (10.5) | (5.5) | (4.5) | (6.2) | (2.9) | (2.7) | (3.3) | — | — |
| Net Income | |||||||||||
| Net Income | (7.0) | (8.2) | (10.5) | (5.5) | (4.5) | (6.2) | (2.9) | (2.7) | (3.3) | (2.7) | (0.2) |
| Per Share | |||||||||||
| Basic EPS | (0.57) | (2.58) | (0.99) | (0.69) | (0.53) | (0.80) | (0.51) | — | — | — | — |
| Diluted EPS | (0.57) | (2.58) | (0.99) | (0.69) | (0.53) | (0.80) | — | — | — | — | — |
| Revenue per Share | 0.13 | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 12.2 | 11.6 | 10.6 | 8.0 | 8.5 | 7.9 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 12.2 | 11.6 | 10.6 | 8.0 | 8.5 | 7.9 | 5.8 | — | — | — | — |
| Supplemental | |||||||||||
| EBITDA | — | (8.1) | (10.0) | (4.6) | (4.1) | (5.8) | (2.4) | (1.9) | (3.3) | — | — |
| EBIT | (7.0) | (8.3) | (10.3) | (4.9) | (4.5) | (6.1) | (2.6) | (2.0) | (3.3) | (2.7) | (0.2) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.